Jay Fitzgerald Dorsey, M.D., Ph.D.
Jay Fitzgerald Dorsey, M.D., Ph.D.
Assistant Professor of Radiation Oncology
Department: Radiation Oncology
Contact information
Department of Radiation Oncology
Perelman Center for Advanced Medicine
TRC2W 3400 Civic Center Blvd
Philadelphia, PA 19104
Perelman Center for Advanced Medicine
TRC2W 3400 Civic Center Blvd
Philadelphia, PA 19104
Office: (215) 662-2428
Fax: (215) 349-5445
Fax: (215) 349-5445
Email:
jayd@uphs.upenn.edu
jayd@uphs.upenn.edu
Publications
Education:
BSChE (Chemical Engineering)
University of Florida, 1995.
MSChE (Chemical Engineering)
University of South Florida, 1997.
M.D.
University of South Florida College of Medicine, 2003.
Ph.D.
University of South Florida (H. Lee Moffitt Cancer Research Institute), 2003.
Permanent linkBSChE (Chemical Engineering)
University of Florida, 1995.
MSChE (Chemical Engineering)
University of South Florida, 1997.
M.D.
University of South Florida College of Medicine, 2003.
Ph.D.
University of South Florida (H. Lee Moffitt Cancer Research Institute), 2003.
Description of Research Expertise
I conduct brain tumor research and specialize in treatment of patients with intracranial malignancies. I have scientific expertise in the areas of signal transduction, molecular therapeutics, brain tumor biology, and radiation biology. As a translational researcher, I am actively involved in basic mechanistic studies, the application of in vivo imaging methods to preclinical studies in relevant biological models of cancer, and early phase clinical trials in intracranial malignancies (as lead principal investigator). In a broad sense, my research focuses on understanding the underlying mechanisms whereby cancers demonstrate resistance to radiation and chemotherapy and characterizing normal cell/tissue responses to radiation therapy. This information will give us a framework to develop ways to target oncogenic pathways that lead to therapeutic resistance and identify potential molecular interventions that may reduce the normal tissue complications of radiation therapy. One major focus concerns the elucidation of the mechanism whereby ER stress modulates death receptor expression and initiation of apoptosis. A second area of interest is the application of in vivo imaging methods to preclinical studies in relevant biological models of cancer with a focus on high-grade brain tumor biology. This includes evaluation of the efficacy of novel therapeutic combinations in preclinical animal models and determination of timing, dosage, and in vivo mechanisms of anti-tumor action. In summary, I have a demonstrated record of successful and productive research projects in highly relevant areas of cancer, molecular oncology, and radiation biology.Description of Clinical Expertise
I am a board-certified radiation oncologist who specializes in the treatment of cancers of the central nervous system with conventional radiation, IMRT, or stereotactic radiation. I am certified to perform gamma knife radiosurgery.Selected Publications
Daniel Y. Joh,, Lova Sun, Melissa Stangl, Ajlan Al-Zaki, Surya Murty, James J. Davis, Brian C. Baumann, Michelle Alonso-Basanta, Dongha Bhang, Gary D. Kao, Andrew Tsourkas, and Jay F. Dorsey.: Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization. PLOS ONE 8(4): e62425, April 2013.Sanjay Chandrasekaran, Andrew Hollander, Xiangsheng Xu, Joe Benci, James J. Davis, Jay F. Dorsey, Gary D. Kao: PET IMAGING OF GLIOBLASTOMA MULTIFORME: INTRIGUING CORRELATIONS BETWEEN 18F-FLUOROTHYMIDINE UPTAKE AND MOLECULAR BIOMARKERS. The Scientific World Journal 2013 Notes: Accepted for publication.
Jay F. Dorsey, et al: Cancers of the Central Nervous System (Chapter 66). Abeloff's Clinical Oncology Textbook 2013.
Baumann Brian C, Kao Gary D, Mahmud Abdullah, Harada Takamasa, Swift Joe, Chapman Christina, Xu Xiangsheng, Discher Dennis E, Dorsey Jay F: Enhancing the Efficacy of Drug-loaded Nanocarriers against Brain Tumors by Targeted Radiation Therapy. ONCOTARGET Dec 2012.
Baumann BC, Benci JL, Santoiemma PP, Chandrasekaran S, Hollander AB, Kao GD, Dorsey JF: An Integrated Method for Reproducible and Accurate Image-guided Stereotaxic Cranial Irradiation of Brain Tumors using the Small Animal Radiation Research Platform (SARRP). TRANSLATIONAL ONCOLOGY 5(4), August 2012 Notes: In Press.
Baumann BC, Dorsey JF, Benci JL, Joh DY, Kao GD: Stereotactic Intracranial Implantation and In Vivo Bioluminescent Imaging of Tumor Xenografts in a Mouse Model System of Glioblastoma Multiforme. JOURNAL OF VISUALIZED EXPERIMENTS Aug 2012 Notes: In Press http://www.jove.com/video/4089/stereotactic-intracranial-implantation-vivo-bioluminescent-imaging.
Wang W, Wang X, David G, Dorsey JF: Dissecting the Complex Regulation of Mad4 in Glioblastoma Multiforme Cells. CANCER BIOLOGY & THERAPY 2012 Notes: Accepted for publication.
Tian Xiaobing, Ye Jiangbin, Alonso-Basanta Michelle, Hahn Stephen M, Koumenis Constantinos, Dorsey Jay F: Modulation of chop-dependent DR5 expression by nelfinavir sensitizes glioblastoma multiforme cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). THE JOURNAL OF BIOLOGICAL CHEMISTRY 286(33): 29408-16, Jun 2011.
Mayes Patrick A, Dolloff Nathan G, Daniel Colin J, Liu Jue Judy, Hart Lori S, Kuribayashi Kageaki, Allen Joshua E, Jee David I H, Dorsey Jay F, Liu Yingqiu Y, Dicker David T, Brown J Martin, Furth Emma E, Klein Peter S, Sears Rosalie C, El-Deiry Wafik S: Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3{beta} and CDK1. CANCER RESEARCH 71(15): 5265-75, Jun 2011.
Alonso-Basanta Michelle, Chapman Christina, Dorsey Jay F, Rengan Ramesh, Hahn Stephen M: A glimpse of the future: where will new combinations of diagnostics and therapies take us? CANCER JOURNAL (Sudbury, Mass.) 17(3): 190-4, May-Jun 2011.

